Ledger.Open graph →
SEC Form D · Amendment · filed December 9, 2025

Araceli Biosciences Inc

Offering
$14.1M
Sold
$12.2M
Exemption
Rule 506(b)
Industry
Other Technology
Location
TIGARD, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (27)

Kirk Malloy · Tigard, ORDirectorKirk Malloy · Tigard, ORDirectorNakul Mandan · San Francisco, CADirectorMatt Beaudet · Tigard, ORExec · DirectorBruce Rhine · Tigard, ORDirectorScott Rerucha · BELLEVUE, WADirectorKevin Gabelein · Tigard, ORDirectorShawn Macdonald · Tigard, ORExecJ. William Freytag · Tigard, ORDirectorChris Gurdjian · BELLEVUE, WADirectorJarrett Johnson · BELLEVUE, WADirectorKevin Gabelein · Tigard, ORDirectorBrent Eley · BELLEVUE, WAExecJ. William Freytag · Tigard, ORDirectorSean O'Neill · Tirgard, ORDirectorSamraat Raha · Tigard, ORDirectorChris Steward · BELLEVUE, WAExec · DirectorSamraat Raha · Tigard, ORDirectorMatt Beaudet · Tigard, ORExec · DirectorWilliam Cortelyou · Tigard, ORDirectorPaul Daversa · WESTPORT, CTDirectorWilliam Cortelyou · Tigard, ORDirectorShawn Macdonald · Tigard, ORExecBruce Rhine · Tigard, ORDirectorShakti C'Ganti · Southlake, TXDirectorEd Bachtold · BELLEVUE, WADirectorSean O'Neill · Tirgard, ORDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗